Cargando…

Immune checkpoint inhibitor-related hepatotoxicity: A review

The application of immune checkpoint inhibitors (ICI) in advanced cancer has been a major development in the last decade. The indications for ICIs are constantly expanding into new territory across different cancers, disease stages and lines of therapy. With this increased use, adverse events includ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Remash, Devika, Prince, David S, McKenzie, Catriona, Strasser, Simone I, Kao, Steven, Liu, Ken
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409159/ https://www.ncbi.nlm.nih.gov/pubmed/34539139 http://dx.doi.org/10.3748/wjg.v27.i32.5376

Ejemplares similares

Association between vessels that encapsulate tumour clusters vascular pattern and hepatocellular carcinoma recurrence following liver transplantation
por: Dennis, Claude, et al.
Publicado: (2022)

Immune checkpoint inhibitor-induced colitis: A comprehensive review
por: Som, Aniruddh, et al.
Publicado: (2019)

Differential diagnosis and management of immune checkpoint inhibitor-induced colitis: A comprehensive review
por: Li, Hua, et al.
Publicado: (2021)

Immune checkpoint inhibitor-induced diarrhea/colitis: Endoscopic and pathologic findings
por: Nishida, Tsutomu, et al.
Publicado: (2019)

Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markers
por: Hopkins, Ashley M, et al.
Publicado: (2017)

Faecal microbiota transplantation enhances efficacy of immune checkpoint inhibitors therapy against cancer
por: Kang, Yong-Bo, et al.
Publicado: (2021)

Checkpoint Inhibitors and Hepatotoxicity
por: Malnick, Stephen D. H., et al.
Publicado: (2021)

Checkpoint inhibitors: What gastroenterologists need to know
por: Ahmed, Monjur
Publicado: (2018)

Comprehensive review of hepatotoxicity associated with traditional Indian Ayurvedic herbs
por: Philips, Cyriac Abby, et al.
Publicado: (2020)

Hallmarks of response to immune checkpoint blockade
por: Cogdill, Alexandria P, et al.
Publicado: (2017)

The Current status of steroid-refractory immune-checkpoint-inhibitor-related hepatotoxicity
por: Xing, Hui, et al.
Publicado: (2023)

Hyperprogression under treatment with immune-checkpoint inhibitors in patients with gastrointestinal cancer: A natural process of advanced tumor progression?
por: Wang, Mo-Xuan, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors Induced Hepatotoxicity; Gastroenterologists’ Perspectives
por: Farshidpour, Maham, et al.
Publicado: (2022)

Hepatotoxicity of immune checkpoint inhibitors: What is Currently Known
por: Zheng, Caiyun, et al.
Publicado: (2023)

Overlapping Hepatotoxicity and Colitis Associated with Immune Checkpoint Inhibitors
por: Malik, Alexander, et al.
Publicado: (2023)

Radiotherapy as an immune checkpoint blockade combination strategy for hepatocellular carcinoma
por: Lee, Byung Min, et al.
Publicado: (2021)

Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors
por: Personeni, Nicola, et al.
Publicado: (2021)

Angiogenesis and immune checkpoint dual blockade: Opportunities and challenges for hepatocellular carcinoma therapy
por: Li, Si-Qi, et al.
Publicado: (2022)

Use of programmed cell death protein ligand 1 assay to predict the outcomes of non-small cell lung cancer patients treated with immune checkpoint inhibitors
por: Tibaldi, Carmelo, et al.
Publicado: (2017)

The decatenation checkpoint
por: Damelin, M, et al.
Publicado: (2007)

G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer
por: Bucher, N, et al.
Publicado: (2008)

Hepatotoxicity in immune checkpoint inhibitors: A pharmacovigilance study from 2014–2021
por: Xu, Ze, et al.
Publicado: (2023)

Immune-related adverse events induced by programmed death protein-1 inhibitors from the perspective of lymphoma immunotherapy
por: Hou, Yong-Zhe, et al.
Publicado: (2023)

Role of Spillover and Spillback in SARS-CoV-2 Transmission and the Importance of One Health in Understanding the Dynamics of the COVID-19 Pandemic
por: Sparrer, McKenzie N., et al.
Publicado: (2023)

Hepatitis B virus-persistent infection and innate immunity defect: Cell-related or virus-related?
por: Tang, Jian, et al.
Publicado: (2018)

Hepatitis B: Who should be treated?-managing patients with chronic hepatitis B during the immune-tolerant and immunoactive phases
por: Kawanaka, Miwa, et al.
Publicado: (2021)

COVID-19 related biliary injury: A review of recent literature
por: Yadlapati, Sujani, et al.
Publicado: (2023)

Allergen Delivery Inhibitors: A Rationale for Targeting Sentinel Innate Immune Signaling of Group 1 House Dust Mite Allergens through Structure-Based Protease Inhibitor Design
por: Zhang, Jihui, et al.
Publicado: (2018)

Immunological aspects of age-related diseases
por: Isobe, Ken-ichi, et al.
Publicado: (2017)

Checkpoint inhibitor-induced hepatotoxicity: Role of liver biopsy and management approach
por: Bessone, Fernando, et al.
Publicado: (2022)

Widespread use of gastric acid inhibitors in infants: Are they needed? Are they safe?
por: Safe, Mark, et al.
Publicado: (2016)

Immune Checkpoint Inhibitor Associated Hepatotoxicity in Primary Liver Cancer Versus Other Cancers: A Systematic Review and Meta‐Analysis
por: Fu, Jianyang, et al.
Publicado: (2021)

Carbo[n]helicenes Restricted to Enantiomerize: An Insight into the Design Process of Configurationally Stable Functional Chiral PAHs
por: Ravat, Prince
Publicado: (2020)

Mycophenolate mofetil for immune checkpoint inhibitor‐related hepatotoxicity relapsing during dose reduction of corticosteroid: A report of two cases and literature review
por: Ueno, Masayuki, et al.
Publicado: (2022)

Alterations of autophagic and innate immune responses by the Crohn’s disease-associated ATG16L1 mutation
por: Okai, Natsuki, et al.
Publicado: (2022)

Evaluation of liver enzyme elevations and hepatotoxicity in patients treated with checkpoint inhibitor immunotherapy
por: Cunningham, Morven, et al.
Publicado: (2021)

Revealing the role of CD4(+) T cells in viral immunity
por: Sant, Andrea J., et al.
Publicado: (2012)

Updated review on immune factors in pathogenesis of Crohn’s disease
por: Li, Na, et al.
Publicado: (2018)

Liver immunity, autoimmunity, and inborn errors of immunity
por: Parlar, Yavuz Emre, et al.
Publicado: (2023)

COX inhibitors and breast cancer
por: Mazhar, D, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_qdrihb0uijgg9q0616scrj3ste